Publications by authors named "Jose Valero-Rosa"

Claim this Profile
D
Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?
Enrique Gomez-Gomez, Sara Moreno Sorribas, Jose Valero-Rosa, Ana Blanca, Juan Mesa

Diagnostics (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance.
Joseba Salguero, Enrique Gómez-Gómez, José Valero-Rosa, Julia Carrasco-Valiente, Juan Mesa

Korean J Radiol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-Center Experience With Third and Fourth Kidney Transplants and Second Kidney Transplant After Pancreas-Kidney Transplant: Surgical Aspects and Outcomes.
Joseba Salguero Segura, José Valero Rosa, Enrique Gomez, María Dolores Navarro Cabello, Jesus Ruiz Garcia

Exp Clin Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL.
Enrique Gomez Gomez, Juan José Salamanca Bustos, Julia Carrasco Valiente, Jose Luis Fernandez Rueda, Ana Blanca

BMJ Open· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer.
Enrique Gómez-Gómez, Juan M. Jiménez-Vacas, Sergio Pedraza-Arévalo, Fernando López-López, Vicente Herrero-Aguayo, José Valero-Rosa

J Clin Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer.
Maria Frantzi, Enrique Gomez Gomez, Ana Blanca Pedregosa, José Valero Rosa, Agnieszka Latosinska

Br J Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical association of metabolic syndrome, C-reactive protein and testosterone levels with clinically significant prostate cancer.
Enrique Gómez-Gómez, Julia Carrasco-Valiente, Juan Pablo Campos-Hernández, Ana Maria Blanca-Pedregosa, Juan Manuel Jiménez-Vacas, Jose Valero-Rosa

J Cell Mol Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Approach to Guide Target Prostate Biopsy: Technique and Initial Experience.
Enrique Gómez Gómez, José Valero Rosa, Julia Carrasco Valiente, Francisco Triviño Tarradas, Francisco Anglada Curado

Urology· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer.
Enrique Gómez-Gómez, Juan M Jiménez-Vacas, Julia Carrasco-Valiente, Vicente Herrero-Aguayo, Ana M Blanca-Pedregosa, José Valero-Rosa

J Cell Mol Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer.
Daniel Hormaechea-Agulla, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, Fernando L-López, Julia Carrasco-Valiente, José Valero-Rosa

FASEB J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness.
Daniel Hormaechea-Agulla, Manuel D Gahete, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, Alejandro Ibáñez-Costa, José Valero-Rosa

Mol Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Randomized Study of Screening for Prostate Cancer Risk Calculator: External Validation, Variability, and Clinical Significance.
Enrique Gómez-Gómez, Julia Carrasco-Valiente, Ana Blanca-Pedregosa, Beatriz Barco-Sánchez, Jose Luis Fernandez-Rueda, Jose Valero-Rosa

Urology· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker.
Daniel Hormaechea-Agulla, Enrique Gómez-Gómez, Alejandro Ibáñez-Costa, Julia Carrasco-Valiente, Esther Rivero-Cortés, José Valero-Rosa

Cancer Lett· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative surgery for rare cases of anterior urethral metastasis in prostate cancer.
Enrique Gómez Gómez, Jose Carlos Carrasco Aznar, Maria Del Mar Moreno Rodríguez, José Valero Rosa, Maria José Requena Tapia

Case Rep Urol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Current recommendations about the diagnosis and treatment of testosterone deficit syndrome: Clinical guidelines].
José Valero Rosa, Javier Márquez López, Pablo Campos Hernández, Ana Puigvert Martínez, Rafael Prieto Castro

Arch Esp Urol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis